JI130
CAS No. 2234271-86-2
JI130 ( —— )
Catalog No. M28784 CAS No. 2234271-86-2
JI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 285 | Get Quote |
|
10MG | 456 | Get Quote |
|
25MG | 743 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | 1377 | Get Quote |
|
500MG | 2673 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJI130
-
NoteResearch use only, not for human use.
-
Brief DescriptionJI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.
-
DescriptionJI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2234271-86-2
-
Formula Weight376.5
-
Molecular FormulaC23H24N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cccc2c1[nH]cc2/C=C/C(NCCc(cccc1)c1OCC=C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Araújo FA, Rocha MA, Capettini LS, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice. APMIS. 2012 24.
molnova catalog
related products
-
H-ASP-PHE-OH
Used as pharmaceutical intermediates.
-
PACAP-Related Peptid...
PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies.
-
BAPTA
BAPTA is a neuroprotective agent in cerebral ischemia acting as an intercellular Ca2+ chelator.